DEA Issues Final Order and Proposed Rule On Synthetic Cannabinoids

The Drug Enforcement Administration (DEA) issued a final order February 29, 2012 to extend the temporary scheduling of the five synthetic cannabinoids into Schedule 1 drugs of the Controlled Substances Act (CSA):

(“1-pentyl-3- (1-naphthoyl)indole (JWH018), 1-butyl- 3-(1-naphthoyl)indole (JWH073), 1-[2- (4-morpholinyl)ethyl]-3-(1- naphthoyl)indole (JWH200), 5-(1,1- dimethylheptyl)-2-(3- hydroxycyclohexyl)-phenol (CP 47,497), and 5-(1,1-dimethyloctyl)-2-(3- hydroxycyclohexyl)-phenol (cannabicyclohexanol, CP47,497 C8 homologue) including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible”)

The temporary scheduling of these synthetic cannabinoids was due to expire on the 29th of February and has been extended through August 29th of this year or until rulemaking proceedings are completed, whichever occurs first.

Please click here to see this order or copy and paste the following link into your web browser:

The DEA followed-up yesterday’s order with a proposed rule in today’s Federal Register. This proposed rule will permanently classify the five synthetic cannabinoids as Schedule 1 drugs. The DEA is now accepting written and electronic comments on this proposal through April 30, 2012.

The DEA asks that all comments reference “Docket No. DEA – 345” to ensure proper handling and receipt. Electronic comments can be submitted using the electronic comment form found at the following link:!home

Written comments can be submitted to: The Drug Enforcement Administration, Attention: DEA Federal Register Representative/OD, 8701 Morrissette Drive, Springfield, VA 22152.

Please click here for the full notice of the proposed rule or copy and paste the following link into your web browser:

Thank you,
DATIA Headquarters